RQM+ Live! #90 – PMCF Surveys That Survive Scrutiny: What Reviewers Want and How to Deliver

PMCF surveys can strengthen your CER and PSUR or create rework. In this 60-minute panel with live audience Q&A, RQM+ leaders from regulatory, clinical, and scientific writing share what MDR reviewers look for and how to design surveys that generate decision-grade evidence. The session is intended for regulatory affairs, post-market surveillance, clinical evidence, and medical writing leaders at MedTech manufacturers. 

Join to learn how to: 

• Define clear objectives, endpoints, and target population so the survey maps to your PMCF plan and CER. 
• Improve response rates without bias and capture higher-quality data, including adverse events and usability feedback. 
• Learn how to position your physician level survey as a chart review. 
• Document methods, rationales, and traceability so notified bodies can follow the logic. 
• Avoid the top reasons reviewers push back on PMCF surveys and how to correct them. 

Walk away with a practical checklist to pressure test your next PMCF survey and reduce review risk. 

Who should attend: 

• Regulatory affairs leaders and PMS managers. 
• Clinical evidence and clinical operations leads. 
• Scientific and medical writing leaders, including CER and PSUR authors. 
• Quality leaders responsible for post market surveillance programs. 

Panelists and moderator: 

• Torrie DeGennaro – Vice President, Scientific & Medical Writing 
• Bethany Chung, Ph.D., RAC – Director, Technical Solutions & Innovation 
• Garrett Jeffries, Ph.D. – Principal 
• Jon Gimbel, Ph.D. – Vice President, Regulatory Affairs 

Certificate of attendance available upon request for live attendees.